These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 39054069)
21. VAPB ER-Aggregates, A Possible New Biomarker in ALS Pathology. Cadoni MPL; Biggio ML; Arru G; Secchi G; Orrù N; Clemente MG; Sechi G; Yamoah A; Tripathi P; Orrù S; Manetti R; Galleri G Cells; 2020 Jan; 9(1):. PubMed ID: 31936602 [TBL] [Abstract][Full Text] [Related]
22. VAPB depletion alters neuritogenesis and phosphoinositide balance in motoneuron-like cells: relevance to VAPB-linked amyotrophic lateral sclerosis. Genevini P; Colombo MN; Venditti R; Marcuzzo S; Colombo SF; Bernasconi P; De Matteis MA; Borgese N; Navone F J Cell Sci; 2019 Apr; 132(7):. PubMed ID: 30745341 [TBL] [Abstract][Full Text] [Related]
23. Sequestosome 1 Is Part of the Interaction Network of VAPB. James C; Lenz C; Urlaub H; Kehlenbach RH Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948065 [TBL] [Abstract][Full Text] [Related]
24. New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Landers JE; Leclerc AL; Shi L; Virkud A; Cho T; Maxwell MM; Henry AF; Polak M; Glass JD; Kwiatkowski TJ; Al-Chalabi A; Shaw CE; Leigh PN; Rodriguez-Leyza I; McKenna-Yasek D; Sapp PC; Brown RH Neurology; 2008 Apr; 70(14):1179-85. PubMed ID: 18322265 [TBL] [Abstract][Full Text] [Related]
25. ALS/FTD-associated FUS activates GSK-3β to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. Stoica R; Paillusson S; Gomez-Suaga P; Mitchell JC; Lau DH; Gray EH; Sancho RM; Vizcay-Barrena G; De Vos KJ; Shaw CE; Hanger DP; Noble W; Miller CC EMBO Rep; 2016 Sep; 17(9):1326-42. PubMed ID: 27418313 [TBL] [Abstract][Full Text] [Related]
26. Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Kabashi E; El Oussini H; Bercier V; Gros-Louis F; Valdmanis PN; McDearmid J; Mejier IA; Dion PA; Dupre N; Hollinger D; Sinniger J; Dirrig-Grosch S; Camu W; Meininger V; Loeffler JP; René F; Drapeau P; Rouleau GA; Dupuis L Hum Mol Genet; 2013 Jun; 22(12):2350-60. PubMed ID: 23446633 [TBL] [Abstract][Full Text] [Related]
27. VAPB interacts with and modulates the activity of ATF6. Gkogkas C; Middleton S; Kremer AM; Wardrope C; Hannah M; Gillingwater TH; Skehel P Hum Mol Genet; 2008 Jun; 17(11):1517-26. PubMed ID: 18263603 [TBL] [Abstract][Full Text] [Related]
28. A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect. Tran D; Chalhoub A; Schooley A; Zhang W; Ngsee JK J Cell Sci; 2012 Jun; 125(Pt 12):2831-6. PubMed ID: 22454507 [TBL] [Abstract][Full Text] [Related]
29. Atypical familial amyotrophic lateral sclerosis with initial symptoms of pain or tremor in a Chinese family harboring VAPB-P56S mutation. Di L; Chen H; Da Y; Wang S; Shen XM J Neurol; 2016 Feb; 263(2):263-268. PubMed ID: 26566915 [TBL] [Abstract][Full Text] [Related]
30. Amyotrophic lateral sclerosis-associated Vap33 is required for maintaining neuronal dendrite morphology and organelle distribution in Drosophila. Kamemura K; Chen CA; Okumura M; Miura M; Chihara T Genes Cells; 2021 Apr; 26(4):230-239. PubMed ID: 33548103 [TBL] [Abstract][Full Text] [Related]
31. Pathomechanisms of ALS8: altered autophagy and defective RNA binding protein (RBP) homeostasis due to the VAPB P56S mutation. Tripathi P; Guo H; Dreser A; Yamoah A; Sechi A; Jesse CM; Katona I; Doukas P; Nikolin S; Ernst S; Aronica E; Glaß H; Hermann A; Steinbusch H; Feller AC; Bergmann M; Jaarsma D; Weis J; Goswami A Cell Death Dis; 2021 May; 12(5):466. PubMed ID: 33972508 [TBL] [Abstract][Full Text] [Related]
36. The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control. Moustaqim-Barrette A; Lin YQ; Pradhan S; Neely GG; Bellen HJ; Tsuda H Hum Mol Genet; 2014 Apr; 23(8):1975-89. PubMed ID: 24271015 [TBL] [Abstract][Full Text] [Related]
37. Human VAPA and the yeast VAP Scs2p with an altered proline distribution can phenocopy amyotrophic lateral sclerosis-associated VAPB(P56S). Nakamichi S; Yamanaka K; Suzuki M; Watanabe T; Kagiwada S Biochem Biophys Res Commun; 2011 Jan; 404(2):605-9. PubMed ID: 21144830 [TBL] [Abstract][Full Text] [Related]
38. ER stress and unfolded protein response in amyotrophic lateral sclerosis. Kanekura K; Suzuki H; Aiso S; Matsuoka M Mol Neurobiol; 2009 Apr; 39(2):81-9. PubMed ID: 19184563 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. Chen HJ; Anagnostou G; Chai A; Withers J; Morris A; Adhikaree J; Pennetta G; de Belleroche JS J Biol Chem; 2010 Dec; 285(51):40266-81. PubMed ID: 20940299 [TBL] [Abstract][Full Text] [Related]
40. Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Mórotz GM; De Vos KJ; Vagnoni A; Ackerley S; Shaw CE; Miller CC Hum Mol Genet; 2012 May; 21(9):1979-88. PubMed ID: 22258555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]